11 Results for "

Substance P TFA

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Substance P TFA" in MCE Product Catalog:

33
33 Cited Publications
Cat. No.: HY-P0201A
CAS No.: 148470-19-3
Synonyms: Neurokinin P TFA
Substance P TFA (Neurokinin P TFA) is a CNS-penetrant neuropeptide, acting as a neurotransmitter and as a neuromodulator in the CNS. The endogenous receptor for substance P is neurokinin 1 receptor (NK1-receptor, NK1R) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1376A
Research Areas:  

Endocrinology

G-Protein antagonist peptide TFA is a truncated substance P-related peptide, competes with receptor for G protein binding. G-Protein antagonist peptide TFA inhibits the activation of Gi or Go by M2 muscarinic cholinergic receptor (M2 mAChR) or of Gs by beta-adrenergic receptor in the reconstituted phospholipid vesicles, assayed by receptor-promoted GTP hydrolysis .
loading...
    loading...
Cat. No.: HY-P0242A
CAS No.: 101536-55-4
Neurokinin B TFA is a tachykinin family peptide that preferentially binds to and activates NK3R over other tachykinin receptors. Neurokinin B TFA preferentially binds to the substance P receptor (SP-N receptor) and mediates acetylcholine release from cholinergic neurons. Neurokinin B TFA regulates the pulsatile release of Kisspeptin and GnRH, stimulates or inhibits the secretion of luteinizing hormone (HY-P2293), regulates reproductive function via metabolic signals, and drives the onset of puberty. Neurokinin B TFA exerts vasoactive effects and induces contraction of isolated guinea pig ileum. Neurokinin B TFA can be used in studies related to hypogonadotropic hypogonadism .
loading...
    loading...
Cat. No.: HY-P0201AF
Research Areas:  

Cancer

Substance P, FAM-labeled (TFA) is Substance P TFA (HY-P02101A) labeled with FAM fluorophore. Substance P TFA (Neurokinin P TFA) is a neuropeptide that acts as a neurotransmitter and neuromodulator in the central nervous system. The endogenous receptor of Substance P is neurokinin 1 receptor (NK1R) .
loading...
    loading...
Cat. No.: HY-P1485A
CAS No.: 2828433-22-1
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Endocrinology

Substance P(1-7) TFA is a fragment of the neuropeptide, substance P (SP). Substance P(1-7) TFA gives depressor and bradycardic effects when applied to the nucleus tractus solitarius .
loading...
    loading...
Cat. No.: HY-P3890A
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease

Substance P (5-11) TFA TFA, the C-terminal heptapeptide of Substance P (HY-P0201), is a neuropeptide. Substance P (5-11) TFA TFA binds to NK-1 tachykinin receptor .
loading...
    loading...
Cat. No.: HY-P1498A
Substance P, Free Acid TFA is a native substance P analog, but shows no biological activity of substance P .
loading...
    loading...
Cat. No.: HY-P1375A
Target:  

mAChR

Research Areas:  

Endocrinology

[D-Trp7,9,10]-Substance P TFA is a substance P analogue. Substance P stimulates substance P receptors but also inhibits ion conductance through nicotinic acetylcholine receptors .
loading...
    loading...
Cat. No.: HY-P1012A
CAS No.: 2828433-10-7
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Endocrinology

[Sar9,Met(O2)11]-Substance P TFA is a tachykinin NK1 receptor selective agonist.
loading...
    loading...
Cat. No.: HY-P0221B
Target:  

PACAP Receptor

Research Areas:  

Endocrinology

PACAP (1-38) free acid TFA is an endogenous neuropeptide. PACAP (1-38) free acid TFA potently stimulates antral motility and somatostatin secretion, inhibits the secretion of gastrin and stimulates the release of vasoactive intestinal polypeptide, gastrin releasing peptide and substance P. PACAP (1-38) free acid TFA also enhances N-methyl-D-aspartate receptor function and expression of brain-derived neurotrophic factor through RACK1 .
loading...
    loading...
Cat. No.: HY-P1194A
Target:  

Neurokinin Receptor

Research Areas:  

Inflammation/Immunology

Spantide I TFA, a substance P analog, is a selective NK1 receptor antagonist, with Ki values of 230 nM and 8150 nM for NK1 and NK2 receptor, respectively. Spantide I provides an approach to reduce type 1 and enhance the type 2 cytokine IL-10 in the infected cornea, leading to a significant reduction in corneal perforation .
loading...
    loading...
  • 1